| Product Code: ETC11489369 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Cannabis Pharmaceuticals Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 Mexico Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 Mexico Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Mexico Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mexico Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Mexico Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Mexico Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Mexico Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Changing regulatory landscape towards cannabis pharmaceuticals in Mexico |
4.2.2 Increasing awareness and acceptance of medical cannabis for various health conditions |
4.2.3 Growing investments in research and development for cannabis-based pharmaceutical products |
4.3 Market Restraints |
4.3.1 Limited availability of approved cannabis pharmaceutical products in the market |
4.3.2 High costs associated with cannabis pharmaceuticals due to production and distribution challenges |
5 Mexico Cannabis Pharmaceuticals Market Trends |
6 Mexico Cannabis Pharmaceuticals Market, By Types |
6.1 Mexico Cannabis Pharmaceuticals Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.4 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Oils, 2021 - 2031F |
6.1.5 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Topicals, 2021 - 2031F |
6.2 Mexico Cannabis Pharmaceuticals Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Anxiety Relief, 2021 - 2031F |
6.2.4 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Skin Conditions, 2021 - 2031F |
6.3 Mexico Cannabis Pharmaceuticals Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.3 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Mexico Cannabis Pharmaceuticals Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Cannabis-Based, 2021 - 2031F |
6.4.3 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Hemp-Based, 2021 - 2031F |
6.4.4 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 Mexico Cannabis Pharmaceuticals Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Non-Psychoactive, 2021 - 2031F |
6.5.3 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Natural, 2021 - 2031F |
6.5.4 Mexico Cannabis Pharmaceuticals Market Revenues & Volume, By Anti-Inflammatory, 2021 - 2031F |
7 Mexico Cannabis Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Mexico Cannabis Pharmaceuticals Market Export to Major Countries |
7.2 Mexico Cannabis Pharmaceuticals Market Imports from Major Countries |
8 Mexico Cannabis Pharmaceuticals Market Key Performance Indicators |
8.1 Number of clinical trials conducted for cannabis pharmaceuticals in Mexico |
8.2 Patient adoption rate of cannabis pharmaceutical products |
8.3 Number of partnerships between pharmaceutical companies and cannabis producers in Mexico |
9 Mexico Cannabis Pharmaceuticals Market - Opportunity Assessment |
9.1 Mexico Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Mexico Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mexico Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Mexico Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Mexico Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 Mexico Cannabis Pharmaceuticals Market - Competitive Landscape |
10.1 Mexico Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Mexico Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here